SCHEMBL388338

SCHEMBL388338

CCOC(=O)/C(C)=N\NC

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.68
ALDH1A1 P00352 4/20 0.42
LMNA P02545 1/20 0.42
HSD17B10 Q99714 1/20 0.42
GLO1 Q04760 1/20 0.42
GAA P10253 3/20 0.41
MGAM O43451 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
EGLN1 Q9GZT9 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
PKM P14618 2/20 0.37
KDM4E B2RXH2 1/20 0.37
CYP2D6 P10635 1/20 0.37
ABCB1 P08183 1/20 0.37
TSHR P16473 1/20 0.36
THRB P10828 1/20 0.36
ALOX15 P16050 1/20 0.36
SOAT1 P35610 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL388339 1.00 MAPT (0.68) MAPTALDH1A1LMNAHSD17B10GLO1
SCHEMBL25703933 1.00 MAPT (0.68) MAPTALDH1A1LMNAHSD17B10GLO1
SCHEMBL13952033 0.84 MAPT (0.50) MAPTALDH1A1LMNAHSD17B10GLO1
SCHEMBL246273 0.80 ABCB1 (0.49) MAPTALDH1A1LMNAHSD17B10GLO1
SCHEMBL13901633 0.80 MAPT (0.48) MAPTALDH1A1LMNAHSD17B10GLO1
SCHEMBL9523119 0.79 MAPT (0.75) MAPTALDH1A1LMNAHSD17B10GLO1
SCHEMBL16619928 0.78 MAPT (0.61) MAPTALDH1A1LMNAHSD17B10GLO1
SCHEMBL1805493 0.78 MAPT (0.72) MAPTALDH1A1LMNAHSD17B10GLO1
SCHEMBL13373635 0.78 MAPT (0.72) MAPTALDH1A1LMNAHSD17B10GLO1
SCHEMBL12386668 0.78 MAPT (0.72) MAPTALDH1A1LMNAHSD17B10GLO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239755-A1 SUBSTITUTED PYRIDAZINONES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES BAYER AKTIENGESELLSCHAFT (DE) 2024-07-18 US disclosed
EP-4330234-A1 SUBSTITUTED PYRIDAZINONES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES Bayer Aktiengesellschaft (DE) 2024-03-06 EP disclosed
WO-2022229055-A1 SUBSTITUTED PYRIDAZINONES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES BAYER AKTIENGESELLSCHAFT (DE) 2022-11-03 WO disclosed
EP-3169668-B1 HERBICIDAL PYRIDAZINONE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2019-09-04 EP disclosed
US-9944608-B2 Herbicidal pyridazinone derivatives SYNGENTA PARTICIPATIONS AG (CH) 2018-04-17 US disclosed
US-20170166535-A1 HERBICIDAL PYRIDAZINONE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2017-06-15 US disclosed
EP-3169668-A1 HERBICIDAL PYRIDAZINONE DERIVATIVES Syngenta Participations AG (CH) 2017-05-24 EP disclosed
WO-2016008816-A1 HERBICIDAL PYRIDAZINONE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2016-01-21 WO disclosed
US-9096533-B2 Pyridazinone compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-08-04 US disclosed
US-9096534-B2 Pyridazinone compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-08-04 US disclosed
US-20090215834-A1 HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF ARRAY BIOPHARMA INC. (US) 2009-08-27 US disclosed
US-20090209542-A1 HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF ARRAY BIOPHARMA INC. (US) 2009-08-20 US disclosed
US-20090111696-A1 Pyridazinone Compound and Use Thereof as herbicides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-04-30 US disclosed
US-7517994-B2 Heterocyclic inhibitors of MEK and methods of use thereof ARRAY BIOPHARMA INC. (US) 2009-04-14 US disclosed
US-20080280957-A1 Heterocyclic Inhibitors of Mek and Methods of Use Thereof ARRAY BIOPHARMA, INC. (US) 2008-11-13 US disclosed
EP-1967516-A1 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamide derivatives as MEK inhibitors for the treatment of hyperproliferative diseases Array Biopharma, Inc. (US) 2008-09-10 EP disclosed
EP-1922307-A2 HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF Array Biopharma, Inc. (US) 2008-05-21 EP disclosed
US-20070112038-A1 Heterocyclic inhibitors of MEK and methods of use thereof ARRAY BIOPHARMA INC. 2007-05-17 US disclosed
WO-2007044084-A2 HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF ARRAY BIOPHARMA INC. (US) 2007-04-19 WO disclosed
US-20050256123-A1 Heterocyclic inhibitors of MEK and methods of use thereof ARRAY BIOPHARMA INC. 2005-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112038-A1 Heterocyclic inhibitors of MEK and methods of use thereof NRAS, BRAF, MAPK9 MAPT 4827/4885ALDH1A1 1723/4885LMNA 2182/4885
US-20080280957-A1 Heterocyclic Inhibitors of Mek and Methods of Use Thereof BRAF, NRAS, MAP3K1 MAPT 4461/4885ALDH1A1 2121/4885LMNA 2319/4885
US-20240239755-A1 SUBSTITUTED PYRIDAZINONES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES PNPO, WEE1, PDXK MAPT 3170/4885ALDH1A1 428/4885LMNA 2689/4885
US-20090215834-A1 HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF NRAS, BRAF, MAPK9 MAPT 4856/4885ALDH1A1 1533/4885LMNA 2616/4885
US-20170166535-A1 HERBICIDAL PYRIDAZINONE DERIVATIVES HPD, DDT, PDXK MAPT 3377/4885ALDH1A1 184/4885LMNA 2484/4885
US-20050256123-A1 Heterocyclic inhibitors of MEK and methods of use thereof NRAS, BRAF, MAPK9 MAPT 4830/4885ALDH1A1 1992/4885LMNA 2092/4885
US-20090209542-A1 HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF NRAS, BRAF, MAPK9 MAPT 4854/4885ALDH1A1 1327/4885LMNA 2655/4885
US-20090111696-A1 Pyridazinone Compound and Use Thereof as herbicides PDXK, DDT, PLPBP MAPT 3414/4885ALDH1A1 171/4885LMNA 3335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.